CORRECTION article

Front. Pharmacol., 11 January 2023

Sec. Drugs Outcomes Research and Policies

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1123542

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy

  • 1. H. K. College of Pharmacy, Mumbai, India

  • 2. Prin. K. M. Kundanani College of Pharmacy, Mumbai, India

  • 3. Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India

  • 4. Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

  • 5. Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

In the published article, there was an error in Figure 1 as published. The figure erroneously contained two duplicate images. The corrected Figure 1 and its caption appear below.

FIGURE 1

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

breast cancer, cancer, solid lipid nanoparticles, tamoxifen, targeted drug delivery

Citation

Bhagwat GS, Athawale RB, Gude RP, Md S, Alhakamy NA, Fahmy UA and Kesharwani P (2023) Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy. Front. Pharmacol. 13:1123542. doi: 10.3389/fphar.2022.1123542

Received

14 December 2022

Accepted

30 December 2022

Published

11 January 2023

Volume

13 - 2022

Edited and reviewed by

Kaisar Raza, Central University of Rajasthan, India

Updates

Copyright

*Correspondence: Prashant Kesharwani, ; Rajani B. Athawale,

This article was submitted to Drugs Outcomes Research and Policies, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics